Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

fdaoutsideweb_18

Trump’s new FDA nominee advances in the Senate

December 4, 2019 Research and Development Big Pharma, FDA, FDA commissioner, Trump, US Pharma

Dr Stephen Hahn, President Donald Trump’s FDA nominee, has advanced his nomination to the full Senate chamber. The vote was …
News
contraceptive-pills-849413_960_720

Male birth control drug may hold promise for treating lung cancer, Chinese study finds

December 4, 2019 Research and Development Cancer Immunotherapy, Chinese Pharmaceuticals, Male Birth Control, lung cancer

A drug for male birth control may hold promise for treating lung cancer patients when treatments like immunotherapy do not …
News

FDA approves Johnson & Johnson cataract treatment

December 4, 2019 Research and Development

Johnson & Johnson has secured approval from the FDA for its Tecnis Toris II 1-Piece Intraocular Lens (IOL).                                                                               &nbs
News
tecentriq

Roche’s Tecentriq combo scores FDA approval in non-small cell lung cancer

December 4, 2019 Research and Development, Sales and Marketing FDA, NSCLC, Roche, pharma, tecentriq

Roche’s immunotherapy Tecentriq (atelizumab) has chalked up another approval from the FDA, this time in combination with the chemotherapy Abraxane …
News
sang-jin_pak

Exclusive interview: Samsung Bioepis’ Sang-Jin Pak on the rise of biosimilars

December 2, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Samsung Bioepis, biosimilars, pharma

Following on from our focus on biosimilars in our feature last week, you can read Nikhil Patel’s interview with Sang-Jin …
Feature

Roche’s satralizumab shows promise at Phase 3 in neuromyelitis optica spectrum disorder

December 2, 2019 Research and Development, Sales and Marketing Roche, pharma, satralizumab

Roche has presented new data on its interleukin-6 (IL-6) inhibitor satralizumab in the treatment of neuromyelitis optica spectrum disorder (NMOSD), …
News
top_10_image_43

Top Ten most popular articles on Pharmafile.com this week

November 29, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Boris Johnson, Jeremy Corbyn, NHS, Opiod, US, opiod crisis

The NHS was featured heavily in the news this week. Jeremy Corbyn revealed documents detailing previous UK-US discussions in which …
News
merck-keytruda

Prostate Cancer ‘super responders’ could live for two more years on Keytruda

November 28, 2019 Research and Development Cancer, immunotherapy, keytruda, oncology, prostate cancer

Men with advanced prostate cancer, who have exhausted all treatment options, could use the immunotherapy Keytruda (pembrolizumab) to live for …
News
pfizer_building_logo1_19

Pfizer’s Ibrance approved by NICE, to be added to the Cancer Drugs Fund

November 28, 2019 Manufacturing and Production, Research and Development Cancer Drugs Fund, NHS, NICE, Pfizer, breast cancer, ibrance, pharma

Today it was announced that the National Institute for Health and Care Excellence (NICE) has recommended Pfizer’s Ibrance (palbociclib) to …
News
corbyn_nhs

Corbyn reveals documents showing US-UK meetings on deregulating NHS drug pricing

November 27, 2019 Research and Development, Sales and Marketing Jeremy Corbyn, Labour Party, NHS, US, pharma

Labour Leader Jeremy Corbyn has showed off documents that detail secret trade meetings between the US and UK Governments, where …
News
immagine-1

Organisation of Islamic Cooperation sets up new halal pharmaceuticals technical committee

November 27, 2019 Research and Development Arabic, Halal, Organisation of Islamic Cooperation, Saudi Arabia, malaysia

The Organisation of Islamic Cooperation’s (OIC) standards body, the Standards and Metrology Institute for Islamic Countries (SMIIC), has set up …
News
shutterstock_79370437

New ICER report reveals most cost-effective rheumatoid arthritis therapies

November 27, 2019 Research and Development, Sales and Marketing AbbVie, Eli Lilly, Humira, Olumiant, Pfizer, Rinvoq, Xeljanz, pharma

The Institute for Clinical and Economic Review (ICER) has unveiled a new report comparing the clinical efficacy and cost-effectiveness of …
News
images

NICE rejects Keytruda for routine use in NHS bladder cancer treatment

November 27, 2019 Research and Development Cancer Drugs Fund, bladder cancer, cancer research

The National Institute for Health and Care Excellence (NICE) has given an initial ‘no’ for Keytruda’s (pembrolizumab) use in treating …
News
astrazeneca_plaque

AstraZeneca and Novoheart team up to develop human ‘heart-in-a-jar’

November 27, 2019 Research and Development Heart in a Jar, Novoheart, heart disease

AstraZeneca and Novoheart are collaborating on developing a functioning miniature human heart model of heart failure, a first of its …
News

The coming age of biosimilars

November 25, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biosimilars, feature, pharma

With more and more biosimilars securing approval and the sheer potential value they have to offer for healthcare systems around …
Feature
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025